1236764-11-6Relevant articles and documents
HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
-
Paragraph 0457, (2021/02/05)
The present invention relates to heterobicyclic amides and related compounds which are inhibitors of CD38 and are useful in the treatment of cancer.
NEW HSL INHIBITORS USEFUL IN THE TREATMENT OF DIABETES
-
Page/Page column 52, (2011/05/03)
The present invention relates to compounds of formula (I) as well as pharmaceutically acceptable salts thereof. The are useful as HSL inhibitors and may, for example, be used in treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis, and obesity.
AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS
-
Page/Page column 112, (2010/12/17)
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein n, m, A, R1 and R2 have the significance given in claim 1. The compounds are useful as HSL inhibitors for the treatment of diabetes dyslipidemia, atherosclerosis and obesity.